Ovasitol is an inositol supplement that improves how your body responds to insulin, which in turn helps regulate reproductive hormones. Each daily dose delivers 4,000 mg of myo-inositol and 100 mg of D-chiro-inositol in a 40:1 ratio, a combination studied primarily in women with polycystic ovary syndrome (PCOS). Its effects ripple outward from insulin signaling to hormone balance, menstrual regularity, ovulation, and egg quality.
How It Works at the Cellular Level
Inositol is a naturally occurring compound your cells use to relay signals from insulin. When insulin docks on a cell’s surface, inositol molecules inside the cell help pass the message along, telling the cell to absorb glucose from the bloodstream. In PCOS, this signaling pathway often misfires. Cells don’t respond well to insulin, so the body pumps out more and more of it to compensate. That excess insulin then stimulates the ovaries to produce too much testosterone, which disrupts ovulation.
Supplementing with inositol essentially restores the missing link in this chain. Myo-inositol, the larger component, works primarily in the ovaries and other tissues to improve insulin sensitivity. D-chiro-inositol plays a complementary role in tissues that store glycogen, like the liver and muscles. The 40:1 ratio mirrors the natural balance found in the body. Clinical trials show the combination significantly reduces fasting insulin levels and improves HOMA index scores, a standard measure of insulin resistance.
Effects on Reproductive Hormones
The hormone changes are where most people notice Ovasitol’s effects. By lowering insulin levels, the supplement reduces the signal that tells the ovaries to overproduce androgens. In randomized controlled trials, women taking myo-inositol saw significant reductions in both total and free testosterone. One trial found total testosterone dropped to 34.8 ng/dL in the treatment group compared to 109.0 ng/dL in controls. Free testosterone showed similarly dramatic differences: 0.24 ng/dL versus 0.85 ng/dL.
The combination of myo-inositol plus D-chiro-inositol also significantly lowers luteinizing hormone (LH) and the LH-to-FSH ratio, both of which tend to be abnormally elevated in PCOS. At the same time, it increases sex hormone-binding globulin (SHBG), a protein that soaks up excess testosterone circulating in the blood. Higher SHBG means less free testosterone available to cause symptoms like acne, excess hair growth, and hair thinning. Estradiol levels also increase, which supports normal follicle development.
Ovulation and Menstrual Regularity
For many women with PCOS, the most meaningful change is getting a period back. In a 12-week trial using 2,000 mg of myo-inositol twice daily (the same total dose as Ovasitol), 58.3% of participants achieved ovulation and 65.3% reported regular menstrual cycles. Earlier trials similarly found that menstrual cyclicity was restored in women who had been experiencing absent or infrequent periods.
These results typically emerge within two to three months of consistent use. The standard recommendation is to take two servings per day, one in the morning and one in the evening, mixed into water or another beverage.
Egg Quality and IVF Outcomes
Ovasitol’s benefits extend beyond just triggering ovulation. The quality of the eggs that develop also improves. Supplementation reduces the number of degenerated and immature eggs retrieved during IVF cycles, meaning a higher proportion of eggs are viable. In a study of 50 overweight women with PCOS undergoing IVF, those who took myo-inositol for 12 weeks beforehand had a pregnancy rate of 60%, compared to 32% in the control group.
The treated group also needed fewer days of ovarian stimulation (11.5 versus 12.6 days) and lower doses of fertility medications. Estradiol levels at the time of the ovulation trigger were lower as well, which reduces the risk of ovarian hyperstimulation syndrome, a painful and sometimes dangerous side effect of fertility treatment. These benefits aren’t limited to PCOS patients. Non-PCOS women undergoing IVF also showed improved implantation and clinical pregnancy rates when supplementing with 4,000 mg of myo-inositol daily.
Reproductive endocrinologists often recommend starting inositol supplementation three months before beginning an IVF cycle, giving it time to influence the full maturation window of developing follicles.
Effects on Cholesterol and Triglycerides
Insulin resistance doesn’t just affect reproductive health. It also tends to push blood lipids in an unhealthy direction. A meta-analysis of randomized controlled trials found that inositol supplementation significantly reduced triglycerides, total cholesterol, and LDL (“bad”) cholesterol in patients with metabolic conditions. The effect on HDL (“good”) cholesterol was mixed. In women with PCOS specifically, there was a modest increase in HDL. But when myo-inositol and D-chiro-inositol were combined, HDL actually decreased slightly, a finding that’s still not fully understood.
These lipid improvements are a secondary benefit for most people taking Ovasitol, but they’re worth knowing about if you’re managing metabolic health alongside reproductive concerns.
Safety and What to Expect
Inositol at 4,000 mg per day is considered safe and well-tolerated across clinical trials. It’s a naturally occurring sugar alcohol found in fruits, beans, grains, and nuts, so your body already processes it routinely. The most commonly reported side effects at typical doses are mild digestive issues like nausea or bloating, which often resolve as your body adjusts. At very high doses (above 12,000 mg per day), gastrointestinal discomfort becomes more common, but the standard Ovasitol dose stays well below that threshold.
Most people don’t notice dramatic changes in the first few weeks. Hormone levels shift gradually, and improvements in cycle regularity, skin, and other androgen-related symptoms tend to become apparent after six to twelve weeks. If you’re taking Ovasitol to support fertility, the three-month timeline aligns with the roughly 90-day maturation cycle of an egg follicle, so giving it a full three months before evaluating results is reasonable.